Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page
25
Current page
15
8-K File 000-50549

8-K Q3 EARNINGS

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
03 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K SEPT 16 2019

Filing date
17 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
10 Sep 2019
Reporting date
05 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Sep 2019
Reporting date
05 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Sep 2019
Reporting date
09 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Sep 2019
Reporting date
05 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Sep 2019
Reporting date
09 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
29 Aug 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
28 Aug 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-233288

S-8

Filing date
15 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-50549

8-K/A

Filing date
09 Aug 2019
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .